Multiple dopamine D4 receptor variants in the human population

Cited by (960)

Items 501–600 of 960

  1. Dopamine D4 receptor VNTR polymorphism associated with greater risk for substance abuse among adolescents with disruptive behavior disorders: Preliminary results
    Travis T. Mallard, James D. Doorley, Christianne L. Esposito-Smythers, John E. McGeary · 2015 · American Journal on Addictions
  2. Variation in mothers' arginine vasopressin receptor 1a and dopamine receptor D4 genes predicts maternal sensitivity via social cognition
    Esther M. Leerkes, Jinni Su, Susan D. Calkins, Vincent C. Henrich, Andrew Smolen · 2016 · Genes Brain & Behavior
  3. Recent findings leading to the discovery of selective dopamine D4 receptor ligands for the treatment of widespread diseases
    Gianfabio Giorgioni, Fabio Del Bello, Pegi Pavletić, Wilma Quaglia, Luca Botticelli, Carlo Cifani, Emanuela Micioni Di Bonaventura, Maria Vittoria Micioni Di Bonaventura, Alessandro Piergentili · 2020 · European Journal of Medicinal Chemistry
  4. Psychotropic and Neurotropic Activity
    Hans Gerhard Vogel · 2007 · Springer eBooks
  5. The dopamine D4/D2 receptor antagonist affinity ratio as a predictor of anti-aggression medication efficacy
    Rif S. El‐Mallakh, Courtney E. McKenzie · 2013 · Medical Hypotheses
  6. Genes de suscetibilidade no transtorno de déficit de atenção e hiperatividade
    Tatiana Roman, Luís Augusto Rohde, Mara Helena Hutz · 2002 · Brazilian Journal of Psychiatry
  7. The Genetic Studies of Obsessive-Compulsive Disorder and Its Future Directions
    Se Joo Kim, Chan‐Hyung Kim · 2006 · Yonsei Medical Journal
  8. 15 Glutathione in the Nervous System: Roles in Neural Function and Health and Implications for Neurological Disease
    Réka Janáky, Reyniel Cruz-Aguado, Simo S. Oja, C. Shaw · 2007 · Springer eBooks
  9. Report from the third international meeting of the Attention‐Deficit Hyperactivity Disorder Molecular Genetics Network
    Stephen V. Faraone · 2002 · American Journal of Medical Genetics
  10. Genetics of Childhood Disorders: XXII. ADHD, Part 6: The Dopamine D4 Receptor Gene
    Cathy L. Barr · 2001 · Journal of the American Academy of Child & Adolescent Psychiatry
  11. Interaction between the Tryptophan Hydroxylase Gene and the Serotonin Transporter Gene in Schizophrenia but Not in Bipolar or Unipolar Affective Disorders
    Jayanti Chotai, Alessandro Serretti, Cristina Lorenzi · 2004 · Neuropsychobiology
  12. Receptor cloning and heterologous expression — towards a new tool for drug discovery
    Walter H. M. L. Luyten, Jos�e E. Leysen · 1993 · Trends in biotechnology
  13. Management of chronic pain. Part I
    Robert L. Barkin, Timothy R. Lubenow, Stephen P. Bruehl, Brenda Husfeldt, Olga Ivankovich, Stacy J. Barkin · 1996 · Disease-a-Month
  14. Evidence for Receptor Subtypes/Species Variants of Receptors
    Carlo Alberto Maggi · 1994 · Humana Press eBooks
  15. Neuropsychological performance measures as intermediate phenotypes for attention-deficit/hyperactivity disorder: a multiple mediation analysis
    Kamradt, Jaclyn M., Nigg, Joel T., Friderici, Karen H., Nikolas, Molly A. · 2017 · Development and Psychopathology
  16. GENETIC ADDICTION RISK SCORE (GARS) ANALYSIS: EXPLORATORY DEVELOPMENT OF POLYMORPHIC RISK ALLELES IN POLY-DRUG ADDICTED MALES
    Kenneth Blum, John Giordano, Siobhan A. Morse, Yiyun Liu, Jai Tan, Abdalla Bowirrat, Andrew Smolen, Roger Waite, Margaret A. Madigan, Mallory M. Kerner et al. · 2010
  17. Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma
    Pegi Pavletić, Ana Teresa Silva Semeano, Hideaki Yano, Alessandro Bonifazi, Gianfabio Giorgioni, Alessandro Piergentili, Wilma Quaglia, Maria Giovanna Sabbieti, Dimitrios Agas, Giorgio Santoni et al. · 2022 · Journal of Medicinal Chemistry
  18. Endophenotypes as a measure of suicidality
    Dimitry A. Chistiakov, Zurab I. Kekelidze, Vladimir Pavlovich Chekhonin · 2012 · Journal of Applied Genetics
  19. Organotypic Cultures of Prepubertal Mouse Testes: A Method to Study Androgen Action in Sertoli Cells while Preserving their Natural Environment
    Karel De Gendt, Chris McKinnell, Ariane Willems, Philippa T. K. Saunders, Richard M. Sharpe, Nina N. Atanassova, Johannes V. Swinnen, Guido Verhoeven · 2009 · Biology of Reproduction
  20. Further evidence of the limited role of candidate genes in relation to infant–mother attachment outcomes
    Esther M. Leerkes, Lindsey R. Gedaly, Nan Zhou, Susan D. Calkins, Vincent C. Henrich, Andrew Smolen · 2016 · Attachment & Human Development
  21. Real-time assessment of alcohol craving and naltrexone treatment responsiveness in a randomized clinical trial
    Robert Miranda, Hayley Treloar Padovano, Joshua C. Gray, Stephanie Wemm, Alexander Blanchard · 2018 · Addictive Behaviors
  22. Parsing out the role of dopamine D4 receptor gene (DRD4) on alcohol‐related phenotypes: A meta‐analysis and systematic review
    Allison M. Daurio, Sara L. Deschaine, Amirhossein Modabbernia, Lorenzo Leggio · 2019 · Addiction Biology
  23. Dopamine and Working Memory: Genetic Variation, Stress and Implications for Mental Health
    Kristel Klaus, Kyla Pennington · 2019 · Current topics in behavioral neurosciences
  24. DRD4, DRD2, DAT1, and ANKK1 Genes Polymorphisms in Patients with Dual Diagnosis of Polysubstance Addictions
    Jolanta Masiak, Jolanta Chmielowiec, Krzysztof Chmielowiec, Anna Grzywacz · 2020 · Journal of Clinical Medicine
  25. Ethological resolution of behavioral topography and D2-like vs. D1-like agonist responses in congenic D4 dopamine receptor “knockouts”: Identification of D4:D1-like interactions
    Gerard J. O'Sullivan, Anthony Kinsella, David K. Grandy, Orna Tighe, David T. Croke, John L. Waddington · 2005 · Synapse
  26. The effect of chronic administration of sarizotan, 5-HT1A agonist/D3/D4 ligand, on haloperidol-induced repetitive jaw movements in rat model of tardive dyskinesia
    Helen Rosengarten, Gerd D. Bartoszyk, David Quartermain, Yan Lin · 2005 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  27. Expression and characterization of a dopamine D4R variant associated with delusional disorder
    Marie‐Thérèse Zenner, Maria Nobile, Robert A. Henningsen, Enrico Smeraldi, Olivier Civelli, Deborah S. Hartman, Marco Catalano · 1998 · FEBS Letters
  28. The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor
    Edith Heuillet, François Petitet, Serge M. Mignani, Jean-Luc Malleron, Jacques Lavayre, Gervais Neliat, Adam Doble, Jean‐Charles Blanchard · 1996 · European Journal of Pharmacology
  29. Twelve-Nucleotide Repeat Polymorphism of D4 Dopamine Receptor Gene in Chinese Familial Schizophrenic Patients
    Chen‐Jee Hong, Hsien‐Jane Chiu, Yea-Shin Chang, Cho‐Boon Sim · 1998 · Biological Psychiatry
  30. Dopamine receptors and schizophrenia: contribution of molecular genetics and clinical neuropsychology
    Gérard Emilien, Jean‐Marie Maloteaux, Muriel Geurts, Michael John Owen · 1999 · The International Journal of Neuropsychopharmacology
  31. Nonhuman Primate Research Contributions to Understanding Genetic and Environmental Influences on Phenotypic Outcomes across Development
    Allyson J. Bennett, Peter J. Pierre · 2010 · Wiley eBooks
  32. Epidemiology of Attention Deficit Hyperactivity Disorder
    Stephen V. Faraone · 2011 · Wiley eBooks
  33. The molecular genetics of schizophrenia.
    Michael John Owen, Peter McGuffin · 1992 · BMJ
  34. The Brain as a Cultural Artifact: Concepts, Actions, and Experiences within the Human Affective Niche
    Gendron, Maria, Mesquita, Batja, Barrett, Lisa Feldman · 2020 · Culture, Mind, and Brain
  35. Role of Dopamine Receptors in Normal and Tumoral Pituitary Corticotropic Cells and Adrenal Cells
    Mara Boschetti, Federico Gatto, Marica Arvigo, Daniela Espósito, Alberto Rebora, Miryam Talco, Manuela Albertelli, Elena Nazzari, Umberto Goglia, Francesco M. Minuto et al. · 2010 · Neuroendocrinology
  36. Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives
    R. Russo, M. Capasso, P. Paolucci, A. Iolascon, Teddy European Network of Excellence · 2011 · European Journal of Clinical Pharmacology
  37. An association between a dopamine transporter gene (SLC6A3) haplotype and ADHD symptom measures in nonclinical adults
    Janette Tong, Tarrant D.R. Cummins, Beth P. Johnson, Leigh‐Anne McKinley, Hayley E. Pickering, Peter A. J. Fanning, Nicole Stefanac, Daniel P. Newman, Ziarih Hawi, Mark A. Bellgrove · 2015 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  38. Imputation of behavioral candidate gene repeat variants in 486,551 publicly-available UK Biobank individuals
    Richard Border, Andrew Smolen, Robin P. Corley, Michael C. Stallings, Sandra A. Brown, Rand D. Conger, Jaime L. Derringer, M. Brent Donnellan, Brett C. Haberstick, John K. Hewitt et al. · 2019 · European Journal of Human Genetics
  39. Dopamine receptors: Studies on structure and function
    Philip G. Strange · 1996 · Advances in Drug Research
  40. Pharmacogenetics of schizophrenia
    Gavin P. Reynolds, Lucy A. Templeman, Beata R. Godlewska · 2006 · Expert Opinion on Pharmacotherapy
  41. Mesocorticolimbic dopamine functioning in primary psychopathy: A source of within-group heterogeneity
    Bariş O. Yildirim, Jan J. L. Derksen · 2015 · Psychiatry Research
  42. The ADHD-linked human dopamine D4 receptor variant D4.7 induces over-suppression of NMDA receptor function in prefrontal cortex
    Luye Qin, Wenhua Liu, Kaijie Ma, Jing Wei, Ping Zhong, Kei Cho, Zhen Yan · 2016 · Neurobiology of Disease
  43. Pharmacology and Metabolism of Renzapride
    Nicholas L Meyers, Roger I. Hickling · 2008 · Drugs in R&D
  44. Association of VNTR polymorphisms in the MAOA promoter and DRD4 exon 3 with heroin dependence in male Chinese addicts
    Chia-Chang Chien, Chi‐Hung Lin, Yong‐Yuan Chang, For‐Wey Lung · 2010 · The World Journal of Biological Psychiatry
  45. Pharmacogenetics of Antiparkinsonian Drug Treatment: A Systematic Review
    Maurits E. L. Arbouw, Jeroen P.P. van Vugt, Toine C. G. Egberts, Henk‐Jan Guchelaar · 2007 · Pharmacogenomics
  46. Variable number of tandem repeat polymorphisms of DRD4: re-evaluation of selection hypothesis and analysis of association with schizophrenia
    Eiji Hattori, Mizuho Nakajima, Kazuo Yamada, Yoshimi Iwayama, Tomoko Toyota, Naruya Saitou, Takeo Yoshikawa · 2008 · European Journal of Human Genetics
  47. La famille des récepteurs de la dopamine
    Pierre Sokoloff, Marie‐Pascale Martres, Jean‐Charles Schwartz · 1993 · médecine/sciences
  48. Association of long variants of the dopamine D4 receptor exon 3 repeat polymorphism with Parkinson's disease
    Michael Ricketts, Robert M. Hamer, Paul Manowitz, Fei Feng, Jacob I. Sage, Rocco Di Paola, Matthew A. Menza · 1998 · Clinical Genetics
  49. Molecular approaches to child psychopathology.
    John P. Alsobrook, David L. Pauls · 1998 · PubMed
  50. Expression and functional characterisation of a synthetic version of the human D4 dopamine receptor in a stable human cell line
    Mark T. McHale, Martin C. Coldwell, Nicole C. Herrity, Izzy Boyfield, Fiona M. Winn, Stuart Ball, Ted Cook, Jeff H. Robinson, Israel Gloger · 1994 · FEBS Letters
  51. Attention deficit hyperactivity disorder pharmacogenetics: the dopamine transporter and D4 receptor.
    J. McGough · 2012 · Pharmacogenomics (London)
  52. Pharmacogenetically Driven Treatments for Alcoholism
    Albert J. Arias, Richard Andrew Sewell · 2012 · CNS Drugs
  53. Biomarkers to Optimize the Treatment of Nicotine Dependence
    Robert A. Schnoll, Frank T. Leone · 2011 · Biomarkers in Medicine
  54. A meta-analytic evaluation of the endophenotype hypothesis: Effects of measurement paradigm in the psychiatric genetics of impulsivity.
    Katherine Grace Jonas, Kristian E. Markon · 2014 · Journal of Abnormal Psychology
  55. Differential Effect of Dopamine D4 Receptor Activation on Low-Frequency Oscillations in the Prefrontal Cortex and Hippocampus May Bias the Bidirectional Prefrontal–Hippocampal Coupling
    Carolina Wilnerzon Thörn, Vasilios Kafetzopoulos, Bernát Kocsis · 2022 · International Journal of Molecular Sciences
  56. Differential Susceptibility: The Genetic Moderation of Peer Pressure on Alcohol Use
    Amanda M. Griffin, H. Harrington Cleveland, Gabriel L. Schlomer, David J. Vandenbergh, Mark Ethan Feinberg · 2015 · Journal of Youth and Adolescence
  57. Influence of the antipsychotic drug pipamperone on the expression of the dopamine D4 receptor
    Kathleen Van Craenenbroeck, Evelien Gellynck, Béatrice Lintermans, Josée E. Leysen, Hubert H.M. Van Tol, Guy Haegeman, Peter Vanhoenacker · 2006 · Life Sciences
  58. Design, synthesis and biological evaluation of pyridine-phenylpiperazines: A novel series of potent and selective α1a-adrenergic receptor antagonist
    Gee‐Hong Kuo, Catherine P. Prouty, William V. Murray, Virginia L. Pulito, Linda K. Jolliffe, Peter Cheung, Sally S. Varga, Mary F. Evangelisto, Charles Shaw · 2000 · Bioorganic & Medicinal Chemistry
  59. ADHD among adolescents with intellectual disabilities: Pre-pathway influences
    Cameron L. Neece, Bruce L. Baker, Steve S. Lee · 2013 · Research in Developmental Disabilities
  60. Association analysis for dopamine D3 receptor, dopamine D4 receptor and dopamine transporter genetic polymorphisms and P300 event-related potentials for normal young females
    Shih‐Jen Tsai, Younger W.‐Y. Yu, Tai-Jui Chen, Ming‐Chao Chen, Chen‐Jee Hong · 2003 · Psychiatric Genetics
  61. Structural and Functional Characteristics of the Dopamine D4 Receptor
    Hubert H.M. Van Tol · 1997 · Advances in pharmacology
  62. An in-frame deletion in the α2C adrenergic receptor is common in African–Americans
    Jinong Feng, Jian Zheng, Joel E. Gelernter, Henry R. Kranzler, Edwin H. Cook, David A Goldman, Ian Richard Jones, Nick J. Craddock, Leonard L. Heston, Lynn E. DeLisi et al. · 2001 · Molecular Psychiatry
  63. Dopamine D4 Receptor-Mediated Inhibition of Cyclic Adenosine 3',5'-Monophosphate Production Does Not Affect Prolactin Regulation
    Suparna Sanyal, Hubert H.M. Van Tol · 1997 · Endocrinology
  64. Lack of association of polymorphisms in six candidate genes in colombian adhd patients
    Dora Janeth Fonseca, Heidi Mateus, Jubby Marcela Gálvez, Diego A. Forero, Claudia Talero‐Gutiérrez, Alberto Vélez-van-Meerbeke · 2015 · Annals of Neurosciences
  65. The effect of dopamine D 4 receptor density on novelty seeking, activity, social interaction, and alcohol binge drinking in adult mice
    Panayotis K. Thanos, Kareema Roushdy, Zehan Sarwar, Onarae V. Rice, Charles R. Ashby, David K. Grandy · 2015 · Synapse
  66. A peripherally restricted P2Y12 receptor antagonist altered rat tumor incidences with no human relevance: Mode of action consistent with dopamine agonism
    David Brott, Håkan A.S. Andersson, Jane Stewart, Lorna C. Ewart, Greg R. Christoph, Johannes H. Harleman, Duncan Armstrong, Lewis B. Kinter · 2014 · Toxicology Reports
  67. Polymorphism of Dopamine Receptor D4 Exon I Corresponding Region in Chicken
    Akinori Sugiyama, Miho Inoue‐Murayama, Mitsuru Miwa, Riyako Ohashi, Boniface Baboreka KAYANG, Makoto Mizutani, Keijiro Nirasawa, Masaharu Odai, Mitsuru Minezawa, Shigeru Watanabe et al. · 2004 · ZOOLOGICAL SCIENCE
  68. Different effects of five dopamine receptor subtypes on nuclear factor‐κB activity in NG108‐15 cells and mouse brain
    Yusuke Takeuchi, Kohji Fukunaga · 2003 · Journal of Neurochemistry
  69. Candidate gene studies of antipsychotic drug efficacy and drug-induced weight gain
    Anil K. Malhotra · 2004 · Neurotoxicity Research
  70. Catecholamine metabolism and psychiatric or behavioral disorders
    Jacques J. Mallet, Rolando Meloni, Claudine Laurent‐Levinson · 1994 · Current Opinion in Genetics & Development
  71. Lack of cross-tolerance between haloperidol and clozapine towards Fos-protein induction in rat forebrain regions
    Jantiena B. Sebens, Tineke Koch, Jakob Korf · 1996 · European Journal of Pharmacology
  72. Brain σ receptors labelled by [3H]nemonapride
    Daiga Maret Helmeste, Siu Wa Tang, Hong Fang, Ming Li · 1996 · European Journal of Pharmacology
  73. Genetically-predicted prefrontal DRD4 gene expression modulates differentiated brain responses to food cues in adolescent girls and boys
    André Krumel Portella, Afroditi Papantoni, Antoneta T. Joseph, Liuyi Chen, Richard S. Lee, Patrícia Pelufo Silveira, Laurette Dubé, Susan Carnell · 2021 · Scientific Reports
  74. No Evidence for Strong Recent Positive Selection Favoring the 7 Repeat Allele of VNTR in the DRD4 Gene
    Izumi Naka, Nao Nishida, Jun Ohashi · 2011 · PLoS ONE
  75. Predicted DRD4 prefrontal gene expression moderates snack intake and stress perception in response to the environment in adolescents
    André Krumel Portella, Afroditi Papantoni, Catherine Paquet, Spencer Moore, Keri Shiels Rosch, Stewart H. Mostofsky, Richard S. Lee, Kimberly Smith, Robert D. Levitan, Patrícia Pelufo Silveira et al. · 2020 · PLoS ONE
  76. Dopamine D4 receptor gene polymorphism (DRD4 VNTR) moderates real-world behavioural response to the food retail environment in children
    Catherine Paquet, André Krumel Portella, Spencer Moore, Yu Ma, Alain Dagher, Michael Joseph Meaney, James L. Kennedy, Robert D. Levitan, Patrícia Pelufo Silveira, Laurette Dubé · 2021 · BMC Public Health
  77. Neuropharmacology of Dopamine Receptors : Implications in Neuropsychiatric Diseases
    Frank I. Tarazi · 2001 · Sultan Qaboos University medical journal
  78. Association analysis of exon III and exon I polymorphisms of the dopamine D4 receptor locus in Mexican psychotic patients
    Ana Julia Aguirre, Rogelio Apiquián, Ana Fresán, Carlos Sabás Cruz-Fuentes · 2007 · Psychiatry Research
  79. Dopamine D4 receptor gene and religious affiliation correlate with dictator game altruism in males and not females: evidence for gender-sensitive gene × culture interaction
    Yushi Jiang, Rachel Bachner‐Melman, Soo Hong Chew, Richard P. Ebstein · 2015 · Frontiers in Neuroscience
  80. The effects of dopamine receptor genes on the trajectories of sport participation from adolescence through young adulthood
    Chung Gun Lee, Hyo Youl Moon, Seiyeong Park · 2020 · Annals of Human Biology
  81. Dopamine D4 Receptor (DRD4) Gene Polymorphism in the First Psychotic Episode
    Gina Rinetti, Beatríz Camarena, Carlos Cruz, Rogelio Apiquián, Ana Fresán, Francisco Páez, Humberto Nicolini · 2001 · Archives of Medical Research
  82. Discovery, characterization and biological evaluation of a novel (R)-4,4-difluoropiperidine scaffold as dopamine receptor 4 (D4R) antagonists
    Daniel E. Jeffries, Jonathan O. Witt, Andrea L. McCollum, Kayla J. Temple, Miguel A. Hurtado, Joel M. Harp, Anna Louise Blobaum, Craig W. Lindsley, Corey R. Hopkins · 2016 · Bioorganic & Medicinal Chemistry Letters
  83. Origin and divergence of tandem repeats of primate D4 dopamine receptor genes
    Miho Inoue‐Murayama, Osamu Takenaka, Yuichi Murayama · 1998 · Primates
  84. Major affective disorders and schizophrenia: a common molecular signature?
    Ann Van Den Bogaert, Jurgen Del‐Favero, Christine Van Broeckhoven · 2006 · Human Mutation
  85. Association Study Between Genetic Polymorphisms in the 14–3‐3 η Chain and Dopamine D4 Receptor Genes and Alcoholism
    Hiroki Ishiguro, Toshikazu Saito, H. Shibuya, Tadao Arinami · 2000 · Alcoholism Clinical and Experimental Research
  86. Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III seven‐repeat allele and substance abuse in opioid dependent subjects: relationship of treatment retention to genotype and personality
    Haim Mel, Ronit Horowitz, Naomi Ohel, Ilana Kramer, Moshe Kotler, Hagit Cohen, Inga Gritsenko, Richard P. Ebstein · 1998 · Addiction Biology
  87. Dopamine receptors and schizophrenia
    Gavin P. Reynolds · 1996 · Biochemical Society Transactions
  88. Alcohol and anesthetic mechanisms in genetically engineered mice
    Gregg E. Homanics · 1998 · Frontiers in bioscience
  89. Individuals being high in their sensitivity to the environment: Are sensitive period changes in play?
    Judith Regina Homberg, Paola Brivio, Corina U. Greven, Francesca Calabrese · 2024 · Neuroscience & Biobehavioral Reviews
  90. Association between neonatal temperament,SLC6A4,DRD4and a functional polymorphism located inTFAP2B
    José Luis Ivorra, Ursula M. D’Souza, Manuel Jover, M J Arranz, Brenda P. Williams, S. E. Henry, Julio Sanjuán, María Dolores Moltó · 2011 · Genes Brain & Behavior
  91. Pharmacogenetics of drug response in Parkinson's disease
    Eleonora D. Dzoljic, Ivana V. Novaković, Maja Krajinović, Ivan Grbatinić, Vladimir Kostić · 2014 · International Journal of Neuroscience
  92. Palmitoylation of the carboxyl-terminal tail of dopamine D4 receptor is required for surface expression, endocytosis, and signaling
    Xiaowei Zhang, Kyeong‐Man Kim · 2016 · Biochemical and Biophysical Research Communications
  93. Association between temperament in terms of the Regulative Theory of Temperament and DRD4 and DAT1 gene polymorphisms
    Włodzimierz Oniszczenko, Wojciech Łukasz Dragan · 2012 · Comprehensive Psychiatry
  94. Psychotropic and neurotropic activity1
    H. Gerhard Vogel, Wolfgang H. Vogel, Bernward A. Schölkens, Jürgen Sandow, Günter A. Müller, Wolfgang F. Vogel · 2002 · Springer eBooks
  95. Structural Analysis of the Mammalian D2, D3 and D4 Dopamine Receptors
    Kim Arthur Neve, Curtiss J. DuRand, Martha M. Teeter · 2003 · CRC Press eBooks
  96. Chapter 5. Novel Antipsychotics
    Harry R Howard, Thomas Seeger · 1993 · Annual reports in medicinal chemistry
  97. Neurotransmitter Systems in Schizophrenia
    Gavin P. Reynolds · 1995 · International review of neurobiology
  98. Genetics of Gilles de la tourette syndrome
    Kenneth K. Kídd, ANDREW J. PAKSTIS, Peter Heutink, David L. Pauls, Roger Kurlan, J. Weber, P. Wilkie, B.J.M. van de Wetering, Ben A. Oostra · 1992 · Movement Disorders
  99. Which D4 do you have?
    Leslie Lars Iversen · 1992 · Nature
  100. Assortative human pair-bonding for partner ancestry and allelic variation of the dopamine receptor D4 (DRD4) gene
    Dan T. A. Eisenberg, Coren Lee Apicella, Benjamin Campbell, Anna Dreber, Justin R. Garcia, J. Koji Lum · 2008 · Nature Precedings